Protalix BioTherapeutics, Inc. Total Contract Liability
Protalix BioTherapeutics, Inc. (PLX) had Total Contract Liability of $10.00 million as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2020-03-12
- 2019-12-31: Contract with Customer, Liability $10.00M.
- 2019-09-30: Contract with Customer, Liability $40.20M.
- 2019-06-30: Contract with Customer, Liability $42.45M.
- 2019-03-31: Contract with Customer, Liability $42.41M.
| Period end | Contract with Customer, Liability |
|---|---|
| 2019-12-31 | $10.00M 10-K · filed 2020-03-12 |
| 2019-09-30 | $40.20M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $42.45M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $42.41M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $42.90M 10-Q · filed 2019-11-07 |
| 2018-09-30 | $43.28M 10-Q · filed 2019-11-07 |
| 2018-06-30 | $25.06M 10-Q · filed 2019-08-08 |
| 2018-03-31 | $25.03M 10-Q · filed 2019-05-06 |
| 2017-12-31 | $25.02M 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |